Health Results Based Financing Impact Evaluation 2018, Health Facility Midline Survey
Congo, Dem. Rep., 2018
Get MicrodataCreated on
Mar 22, 2021
Last modified
Mar 22, 2021
Page views
20528
94 Pyrazinamide (Q14_16_69)
Data file: f1_facility.dta
Overview
Valid:
167
Invalid:
42
Minimum:
0
Maximum:
500
Type:
Discrete
Decimal:
0
Start:
6570
End:
6572
Width:
3
Range:
0 - 500
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0 | 122 |
73.1%
|
|
| 1 | 22 |
13.2%
|
|
| 2 | 1 |
0.6%
|
|
| 3 | 1 |
0.6%
|
|
| 10 | 2 |
1.2%
|
|
| 15 | 2 |
1.2%
|
|
| 20 | 1 |
0.6%
|
|
| 28 | 4 |
2.4%
|
|
| 29 | 1 |
0.6%
|
|
| 30 | 1 |
0.6%
|
|
| 50 | 1 |
0.6%
|
|
| 100 | 2 |
1.2%
|
|
| 400 | 6 |
3.6%
|
|
| 500 | 1 |
0.6%
|
|
| Sysmiss | 42 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.